Fundraising Fox
Sophia Genetics
Founded 2011 · 506 employees on LinkedIn · 10 known investors
Find your way into Sophia Genetics
SOPHiA GENETICS develops the SOPHiA DDM data analytics platform for genomic and multimodal data analysis, offering solutions used in oncology research and in vitro diagnostics. Its products serve clinical and research institutions, with several CE-IVD diagnostic solutions available across Europe, the UK, Switzerland, and Israel.
Investors · 10
How we know: 360 Capital's portfolio page · Not right? Tell us
How we know: aMoon's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: Invoke Capital's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries EJan 2019
Generation Investment Management (lead), Alychlo, Balderton Capital, Idinvest Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Sophia Genetics do?
- SOPHiA GENETICS develops the SOPHiA DDM data analytics platform for genomic and multimodal data analysis, offering solutions used in oncology research and in vitro diagnostics. Its products serve clinical and research institutions, with several CE-IVD diagnostic solutions available across Europe, the UK, Switzerland, and Israel.
- Who are Sophia Genetics's investors?
- Sophia Genetics's investors include 360 Capital, aMoon, Balderton Capital, Compound, Hitachi Ventures, Invoke Capital, ACE & Company, Alychlo and 2 more.